Cancer Letters
Volume 208, Issue 2 , Pages 179-186 , 28 May 2004

In vivo reversal of doxorubicin resistance by (−)-epigallocatechin gallate in a solid human carcinoma xenograft

Received 22 September 2003 ,Revised 27 January 2004 ,Accepted 28 January 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(04)00137-5

doi: 10.1016/j.canlet.2004.01.033

Cancer Letters
Volume 208, Issue 2 , Pages 179-186 , 28 May 2004